American Oncology Network, Inc.
AONC
$6.01
$0.010.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 485.25M | 465.47M | 431.75M | 361.51M | 320.04M |
| Total Other Revenue | 5.64M | 4.81M | 2.23M | 2.83M | 4.14M |
| Total Revenue | 490.88M | 470.28M | 433.98M | 364.34M | 324.18M |
| Cost of Revenue | 894.07M | 433.75M | 404.59M | 354.95M | 312.85M |
| Gross Profit | 87.70M | 36.53M | 29.39M | 9.39M | 11.34M |
| SG&A Expenses | 71.01M | 34.74M | 36.74M | 28.28M | 30.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 482.54M | 468.48M | 441.33M | 383.23M | 343.45M |
| Operating Income | 8.35M | 1.80M | -7.35M | -18.89M | -19.26M |
| Income Before Tax | 2.33M | -1.28M | -3.45M | -22.07M | -22.29M |
| Income Tax Expenses | -72.00K | -- | -324.00K | 2.89M | 69.00K |
| Earnings from Continuing Operations | 2.41M | -1.28M | -3.13M | -24.96M | -22.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.09M | 208.00K | 6.75M | 17.12M | 18.60M |
| Net Income | 1.32M | -1.07M | 3.62M | -7.84M | -3.75M |
| EBIT | 8.35M | 1.80M | -7.35M | -18.89M | -19.26M |
| EBITDA | 11.40M | 4.36M | -4.96M | -16.38M | -17.18M |
| EPS Basic | 0.00 | -0.19 | 0.12 | -1.22 | -0.74 |
| Normalized Basic EPS | 0.08 | -0.04 | 0.38 | 0.47 | 0.80 |
| EPS Diluted | 0.00 | -0.19 | -0.11 | -1.22 | -0.74 |
| Normalized Diluted EPS | 0.08 | -0.04 | 0.12 | 0.47 | 0.80 |
| Average Basic Shares Outstanding | 23.29M | 13.26M | 11.38M | 7.53M | 6.90M |
| Average Diluted Shares Outstanding | 23.29M | 13.26M | 37.09M | 7.53M | 6.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |